Ardent Health Investors Press Securities Case as Firms Seek Lead Plaintiff by March 9

Overview

• The consolidated securities class action, Postiwala v. Ardent Health, Inc., is pending in the U.S. District Court for the Middle District of Tennessee covering trades from July 18, 2024 to November 12, 2025.
• Multiple investor firms, including Hagens Berman, Rosen, Bleichmar Fonti & Auld, Wolf Haldenstein, Kahn Swick & Foti, and Bragar Eagel & Squire, are recruiting class members ahead of the March 9, 2026 lead‑plaintiff deadline.
• Complaints allege Ardent overstated accounts receivable by relying on a 180‑day “cliff” for reserves despite touting detailed historical reviews, while underestimating professional malpractice exposure.
• On Nov. 12, 2025, Ardent disclosed a roughly $42.6–$43 million Q3 revenue reduction from hindsight evaluations after moving to a new revenue accounting system that recognizes reserves earlier.
• The company simultaneously increased professional liability reserves by about $54 million and cut 2025 EBITDA guidance by roughly $57.5 million at the midpoint, and the stock fell about 33% to $9.30 the next day.